BRNS Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for BRNS (BRNS) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| INMB INmune Bio, Inc. | $1.32 +4.76% |
| KZR Kezar Life Sciences, Inc. | $7.38 +0.27% |
| B Barrick Mining Corporation | $43.06 -1.73% |
| R Ryder System, Inc. | $212.05 -3.54% |
| OKUR OnKure Therapeutics, Inc. | $4.51 -2.06% |
| MDCX Medicus Pharma Ltd. Common Stock | $0.30 -25.04% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| INMB INmune Bio, Inc. | $1.32 | +4.76% | 35.09 M | -0.71 | -1.86 | 0.00% | Hold | 305 |
| KZR Kezar Life Sciences, Inc. | $7.38 | +0.27% | 54.40 M | -0.96 | -7.66 | 0.00% | Hold | 140 |
| B Barrick Mining Corporation | $43.06 | -1.73% | 72.14 B | 14.70 | 2.93 | 1.38% | Buy | 8.55 |
| R Ryder System, Inc. | $212.05 | -3.54% | 8.36 B | 17.67 | 12.00 | 0.86% | Buy | 556 |
| OKUR OnKure Therapeutics, Inc. | $4.51 | -2.06% | 61.67 M | -1.02 | -4.42 | 0.00% | Buy | 181 |
| MDCX Medicus Pharma Ltd. Common Stock | $0.30 | -25.04% | 6.66 M | -0.11 | -2.74 | 0.00% | Buy | 50.13 |
Frequently Asked Questions
What are BRNS's latest financial results?
Review BRNS's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has BRNS's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is BRNS's cash flow situation and liquidity?
Cash flow statements reveal how BRNS generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does BRNS's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether BRNS is outperforming or lagging within its sector.
Are BRNS's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether BRNS's profits are repeatable and supported by strong fundamentals.